ALK Rearrangement in Lung Neuroendocrine Neoplasms: Case Series of Non-Asian Patients With Response to ALK Inhibitors

Clin Lung Cancer. 2021 Sep;22(5):e686-e690. doi: 10.1016/j.cllc.2021.01.004. Epub 2021 Jan 17.
No abstract available

Keywords: Alectinib; Brigatinib; Carcinoid morphology; Crizotinib; Supracarcinoids.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Aged
  • Anaplastic Lymphoma Kinase / drug effects*
  • Anaplastic Lymphoma Kinase / genetics*
  • Carcinoma, Non-Small-Cell Lung / genetics*
  • Carcinoma, Non-Small-Cell Lung / physiopathology*
  • Female
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / physiopathology*
  • Middle Aged
  • Mutation / genetics*
  • Protein Kinase Inhibitors / pharmacology*

Substances

  • Protein Kinase Inhibitors
  • Anaplastic Lymphoma Kinase